Last 12 months
Inside the activity.
2 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantStock Options · Derivative | 70,088 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 7 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,088 Underlying: Common Stock · 70,088 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantRestricted Stock Units · Derivative | 38,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 6 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,411 Underlying: Common Stock · 38,411 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantRestricted Stock Units · Derivative | 32,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 5 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,863 Underlying: Common Stock · 32,863 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantRestricted Stock Units · Derivative | 21,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 4 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,802 Underlying: Common Stock · 21,802 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantRestricted Stock Units · Derivative | 12,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 3 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,031 Underlying: Common Stock · 12,031 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantRestricted Stock Units · Derivative | 13,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 2 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,142 Underlying: Common Stock · 13,142 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:32 UTC |
WIDMER KATHYGroup President LATAM
|
GrantRestricted Stock Units · Derivative | 8,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000062 · wk-form4_1693002714.xml · derivative · entry 1 WIDMER KATHY · CIK 0001482594 · Group President LATAM 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,468 Underlying: Common Stock · 8,468 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:23 UTC |
Sneed Michael EDirector
|
GrantDeferred Share Units · Derivative | 7,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000054 · wk-form4_1693002181.xml · derivative · entry 2 Sneed Michael E · CIK 0001745939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,620 Underlying: Common Stock · 7,620 shares Expires not disclosed F2 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:23 UTC |
Sneed Michael EDirector
|
OtherCommon Stock | 10,787 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001944048-23-000054 · wk-form4_1693002181.xml · nonDerivative · entry 1 Sneed Michael E · CIK 0001745939 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,787 F1 · price: On July 24, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. ("Kenvue") common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:20 UTC |
Ruh PaulChief Financial Officer
|
GrantStock Options · Derivative | 95,899 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000052 · wk-form4_1693002037.xml · derivative · entry 9 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,899 Underlying: Common Stock · 95,899 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:20 UTC |
Ruh PaulChief Financial Officer
|
GrantStock Options · Derivative | 89,913 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000052 · wk-form4_1693002037.xml · derivative · entry 8 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,913 Underlying: Common Stock · 89,913 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:20 UTC |
Ruh PaulChief Financial Officer
|
GrantStock Options · Derivative | 64,569 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000052 · wk-form4_1693002037.xml · derivative · entry 7 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,569 Underlying: Common Stock · 64,569 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:20 UTC |
Ruh PaulChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 27,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000052 · wk-form4_1693002037.xml · derivative · entry 6 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,877 Underlying: Common Stock · 27,877 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:20 UTC |
Ruh PaulChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 22,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000052 · wk-form4_1693002037.xml · derivative · entry 5 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,758 Underlying: Common Stock · 22,758 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:20 UTC |
Ruh PaulChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 20,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000052 · wk-form4_1693002037.xml · derivative · entry 4 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,091 Underlying: Common Stock · 20,091 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:20 UTC |
Ruh PaulChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 8,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000052 · wk-form4_1693002037.xml · derivative · entry 3 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,734 Underlying: Common Stock · 8,734 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:20 UTC |
Ruh PaulChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 9,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000052 · wk-form4_1693002037.xml · derivative · entry 2 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,105 Underlying: Common Stock · 9,105 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:20 UTC |
Ruh PaulChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 7,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000052 · wk-form4_1693002037.xml · derivative · entry 1 Ruh Paul · CIK 0001967445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,801 Underlying: Common Stock · 7,801 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:16 UTC |
PRABHU VASANT MDirector
|
GrantDeferred Share Units · Derivative | 7,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000050 · wk-form4_1693001801.xml · derivative · entry 1 PRABHU VASANT M · CIK 0001209832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,620 Underlying: Common Stock · 7,620 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantStock Options · Derivative | 42,782 | $0.00 Strike: $15.62 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 13 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,782 Underlying: Common Stock · 42,782 shares Expires 2027-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantStock Options · Derivative | 37,707 | $0.00 Strike: $17.49 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 12 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,707 Underlying: Common Stock · 37,707 shares Expires 2028-02-11 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantStock Options · Derivative | 20,913 | $0.00 Strike: $17.82 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 11 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,913 Underlying: Common Stock · 20,913 shares Expires 2029-02-11 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantStock Options · Derivative | 40,589 | $0.00 Strike: $20.44 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 10 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,589 Underlying: Common Stock · 40,589 shares Expires 2030-02-10 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantStock Options · Derivative | 36,426 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 9 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,426 Underlying: Common Stock · 36,426 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantStock Options · Derivative | 32,433 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 8 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,433 Underlying: Common Stock · 32,433 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantStock Options · Derivative | 33,996 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 7 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,996 Underlying: Common Stock · 33,996 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 8,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 6 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,208 Underlying: Common Stock · 8,208 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 10,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 5 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,579 Underlying: Common Stock · 10,579 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 10,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 4 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,586 Underlying: Common Stock · 10,586 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 3,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 3 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,319 Underlying: Common Stock · 3,319 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 3,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 2 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,282 Underlying: Common Stock · 3,282 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:14 UTC |
Orlando MatthewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 4,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000048 · wk-form4_1693001676.xml · derivative · entry 1 Orlando Matthew · CIK 0001967444 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,112 Underlying: Common Stock · 4,112 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantStock Options · Derivative | 432,986 | $0.00 Strike: $20.44 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 10 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432,986 Underlying: Common Stock · 432,986 shares Expires 2030-02-10 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F8 · derivative.exercise_date: This award is fully vested Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantStock Options · Derivative | 514,646 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 9 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,646 Underlying: Common Stock · 514,646 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantStock Options · Derivative | 458,189 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 8 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,189 Underlying: Common Stock · 458,189 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantStock Options · Derivative | 418,970 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 7 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,970 Underlying: Common Stock · 418,970 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 179,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 6 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,515 Underlying: Common Stock · 179,515 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 139,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 5 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,170 Underlying: Common Stock · 139,170 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 156,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 4 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,417 Underlying: Common Stock · 156,417 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 23,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 3 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,432 Underlying: Common Stock · 23,432 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 23,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 2 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,195 Underlying: Common Stock · 23,195 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:12 UTC |
Mongon ThibautDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 25,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000046 · wk-form4_1693001529.xml · derivative · entry 1 Mongon Thibaut · CIK 0001768503 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,314 Underlying: Common Stock · 25,314 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. F2 · derivative.expiration_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:08 UTC |
Meurer JanChief Growth Officer
|
GrantStock Options · Derivative | 61,184 | $0.00 Strike: $22.23 | $0.00 |
DisclosureSEC source: 0001944048-23-000044 · wk-form4_1693001319.xml · derivative · entry 9 Meurer Jan · CIK 0001967057 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,184 Underlying: Common Stock · 61,184 shares Expires 2031-02-08 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:08 UTC |
Meurer JanChief Growth Officer
|
GrantStock Options · Derivative | 45,723 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001944048-23-000044 · wk-form4_1693001319.xml · derivative · entry 8 Meurer Jan · CIK 0001967057 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,723 Underlying: Common Stock · 45,723 shares Expires 2032-02-14 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:08 UTC |
Meurer JanChief Growth Officer
|
GrantStock Options · Derivative | 52,509 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001944048-23-000044 · wk-form4_1693001319.xml · derivative · entry 7 Meurer Jan · CIK 0001967057 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,509 Underlying: Common Stock · 52,509 shares Expires 2033-02-13 F7 · security: These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value. F2 · derivative.exercise_date: This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:08 UTC |
Meurer JanChief Growth Officer
|
GrantRestricted Stock Units · Derivative | 17,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000044 · wk-form4_1693001319.xml · derivative · entry 6 Meurer Jan · CIK 0001967057 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,787 Underlying: Common Stock · 17,787 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:08 UTC |
Meurer JanChief Growth Officer
|
GrantRestricted Stock Units · Derivative | 11,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000044 · wk-form4_1693001319.xml · derivative · entry 5 Meurer Jan · CIK 0001967057 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,572 Underlying: Common Stock · 11,572 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:08 UTC |
Meurer JanChief Growth Officer
|
GrantRestricted Stock Units · Derivative | 16,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000044 · wk-form4_1693001319.xml · derivative · entry 4 Meurer Jan · CIK 0001967057 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,335 Underlying: Common Stock · 16,335 shares Expires not disclosed F5 · security: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F5 · derivative.exercise_price: These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years. F6 · derivative.exercise_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. F6 · derivative.expiration_date: This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:08 UTC |
Meurer JanChief Growth Officer
|
GrantRestricted Stock Units · Derivative | 5,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000044 · wk-form4_1693001319.xml · derivative · entry 3 Meurer Jan · CIK 0001967057 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,571 Underlying: Common Stock · 5,571 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F4 · derivative.exercise_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. F4 · derivative.expiration_date: This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 22:08 UTC |
Meurer JanChief Growth Officer
|
GrantRestricted Stock Units · Derivative | 4,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000044 · wk-form4_1693001319.xml · derivative · entry 2 Meurer Jan · CIK 0001967057 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,630 Underlying: Common Stock · 4,630 shares Expires not disclosed F1 · security: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F1 · derivative.exercise_price: These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value. F3 · derivative.exercise_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. F3 · derivative.expiration_date: This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.